Quote:

---

Pts received 1-33 doses

---

Which tells us that at most patients were treated up to 8 months. The protocol mentioned an average of 6 months for treatment. But the effects of reversal of progression should have lowered mortality well past the point of the last dose.

What that also tells us is the results when treatment is started earlier or not discontinued could be substantially better than the results indicated. With only 1 dose or only a few doses there will be extremely limited benefit. That's why I like data. Knowing how many got only a few doses would give an indication of well leronlimab could actually do.